Skip to content
healthcare.dev
Get a free key

Arexvy

NDC 58160-848, Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted, kit, from GlaxoSmithKline Biologicals SA.

Product NDC
58160-848
Status
Listed
Labeler
GlaxoSmithKline Biologicals SA
Dosage form
KIT
Route
—
Product type
VACCINE
Marketing category
BLA
Application
BLA125775
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58160-848 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
58160-848-11581600848111 KIT in 1 CARTON (58160-848-11) * .5 mL in 1 VIAL (58160-723-03) * .5 mL in 1 VIAL (58160-744-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58160-848 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58160-848 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58160-848. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.